Na Li

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Shengli Xia, Yuntao Zhang, Yanxia Wang et al. · The Lancet Infectious Diseases · 2020 · 1.2K citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +5

Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia

Xiaoyu Han, Yanqing Fan, Osamah Alwalid et al. · Radiology · 2021 · 640 citations · Full text

Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test

Jianghong An, Xuejiao Liao, Tongyang Xiao et al. · Annals of Translational Medicine · 2020 · 160 citations · Full text

Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test

Jianghong An, Xuejiao Liao, Tongyang Xiao et al. · 2020 · 97 citations · Full text

Clinical Symptoms, Viral Diagnostics, Immunodeficiencies +17

Influence of different proton pump inhibitors on the pharmacokinetics of voriconazole

Qi Fang, Liqin Zhu, Na Li et al. · International Journal of Antimicrobial Agents · 2017 · 66 citations

Pharmaceutical Science, Biochemistry, Medicine +6